Article

Transcriptomic profile of <i>MTUS1</i> -low TNBC reveals candidate therapeutic strategies

2026-05-26

Abstract excerpt

<h4>Background</h4> Triple-negative breast cancer (TNBC) is a clinically aggressive breast cancer subtype. It is a heterogeneous disease that remains difficult to stratify and that still lacks durable and biomarker-guided therapeutic options. Low expression of the tumour suppressor MTUS1 is associated with aggressive breast cancer features, but the biological properties of MTUS1 -low TNBC remain insufficiently...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f0497645-d68c-5db8-bcaf-6dad888c39af
DOI: 10.64898/2026.05.22.727134

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Transcriptomic profile of <i>MTUS1</i> -low TNBC reveals candidate therapeutic strategiesDOI 10.64898/2026.05.22.727134Read

Identifying Novel Therapeutic Targets for Overcoming TNBC Chemo Resistance Through Comprehensive CRISPR-Cas9 Genome ScreeningSemantic proximity Read

Genomic screening reveals UBA1 as a potent and druggable target in c-MYC-high TNBC modelsSemantic proximity Read

Single-Cell Transcriptome Analysis Revealed Heterogeneity and Identified Novel Therapeutic Targets for Breast Cancer SubtypesSemantic proximity Read

TK1 in Cancer Progression: elucidating its influence on cellular invasion and survivalSemantic proximity Read

BRCA1 and BRCA2 germline mutations driven signaling pathway alterations are sufficient to initiate breast tumorigenesis by the PIK3CA <sup>H1047R</sup> oncogeneSemantic proximity Read

Single-cell long noncoding RNA (lncRNA) transcriptome implicates MALAT1 in triple-negative breast cancer (TNBC) resistance to neoadjuvant chemotherapySemantic proximity Read

An integrative machine learning approach identifies the centrality of ferroptosis, cuproptosis, and immune pathway crosstalk for breast cancer stratification and therapy guidance.Semantic proximity Read

Robust CRISPR Screens Identify TPL1 as a Novel Long Noncoding RNA Driving Triple-Negative Breast Cancer HallmarksSemantic proximity Read

Integration of multi-omics data shows downregulation of mismatch repair, purin, and tubulin pathways in triple-negative chemotherapy-resistant breast tumorsSemantic proximity Read

Deciphering the gene regulatory circuitry governing chemoresistance in Triple-Negative Breast CancerSemantic proximity Read

Multiomic profiling of LKB1 loss of expression in breast cancerSemantic proximity Read

TP53mutation–associated and copy number–dependent KDM7A-DT expression affects DNA repair and promotes invasive breast cancer progressionSemantic proximity Read